Back to Trades
Mandelia Ashish
VPChief Accounting OfficerCIK 0001782805
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Across 1 filing between 2026, Mandelia Ashish, VP, Chief Accounting Officer, has disclosed $1.7M in transactions — all concentrated in Mersana Therapeutics, Inc. (MRSN). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Jan 6 | MRSN Mersana Therapeutics, Inc. | Mandelia Ashish | VP, Chief Accounting Officer | Disposed | $1.7M |
1 filing